163 related articles for article (PubMed ID: 3097248)
1. 5-HT agonist induced analgesia modulated by central but not peripheral noradrenaline depletion in rats.
Minor BG; Archer T; Post C; Jonsson G; Mohammed AK
J Neural Transm; 1986; 66(3-4):243-59. PubMed ID: 3097248
[TBL] [Abstract][Full Text] [Related]
2. Noradrenergic-serotonergic interactions and nociception in the rat.
Archer T; Jonsson G; Minor BG; Post C
Eur J Pharmacol; 1986 Jan; 120(3):295-307. PubMed ID: 3081358
[TBL] [Abstract][Full Text] [Related]
3. Intrathecal noradrenaline restores 5-methoxy-N,N-dimethyltryptamine induced antinociception abolished by intrathecal 6-hydroxydopamine.
Minor BG; Persson ML; Post C; Jonsson G; Archer T
J Neural Transm; 1988; 72(2):107-20. PubMed ID: 3133452
[TBL] [Abstract][Full Text] [Related]
4. (+)-8-OH-DPAT and 5-MeODMT induced analgesia is antagonised by noradrenaline depletion.
Archer T; Arweström E; Minor BG; Persson ML; Post C; Sundström E; Jonsson G
Physiol Behav; 1987; 39(1):95-102. PubMed ID: 2951756
[TBL] [Abstract][Full Text] [Related]
5. Blockade and reversal of 5-methoxy-N,N-dimethyltryptamine-induced analgesia following noradrenaline depletion.
Archer T; Minor BG; Post C
Brain Res; 1985 Apr; 333(1):55-61. PubMed ID: 3158373
[TBL] [Abstract][Full Text] [Related]
6. Spinal and locus coeruleus noradrenergic lesions abolish the analgesic effects of 5-methoxy-N,N-dimethyltryptamine.
Danysz W; Jonsson G; Minor BG; Post C; Archer T
Behav Neural Biol; 1986 Jul; 46(1):71-86. PubMed ID: 3015120
[TBL] [Abstract][Full Text] [Related]
7. Analgesia induced by 5-hydroxytryptamine receptor agonists is blocked or reversed by noradrenaline-depletion in rats.
Post C; Minor BG; Davies M; Archer T
Brain Res; 1986 Jan; 363(1):18-27. PubMed ID: 3484988
[TBL] [Abstract][Full Text] [Related]
8. Spinal noradrenergic neurotransmission and the analgesia induced by brief footshock.
Danysz W; Minor BG; Jonsson G; Post C; Archer T
Brain Res; 1986 Feb; 365(1):169-73. PubMed ID: 3004654
[TBL] [Abstract][Full Text] [Related]
9. Increased antinociception by alpha-adrenoceptor drugs after spinal cord noradrenaline depletion.
Post C; Persson ML; Archer T; Minor BG; Danysz W; Sundström E
Eur J Pharmacol; 1987 May; 137(1):107-16. PubMed ID: 2886347
[TBL] [Abstract][Full Text] [Related]
10. Blockade of intrathecal 5-hydroxytryptamine-induced antinociception in rats by noradrenaline depletion.
Minor BG; Post C; Archer T
Neurosci Lett; 1985 Feb; 54(1):39-44. PubMed ID: 2983267
[TBL] [Abstract][Full Text] [Related]
11. 5-HT depletion with 5,7-DHT, PCA and PCPA in mice: differential effects on the sensitivity to 5-MeODMT, 8-OH-DPAT and 5-HTP as measured by two nociceptive tests.
Eide PK; Hole K; Berge OG; Broch OJ
Brain Res; 1988 Feb; 440(1):42-52. PubMed ID: 2965956
[TBL] [Abstract][Full Text] [Related]
12. Neonatal intraspinal 6-hydroxydopamine, 5,7-dihydroxytryptamine or their combination: effects on nociception and morphine analgesia.
Pappas B; Ings R; Roberts D
Eur J Pharmacol; 1982 Dec; 86(2):157-66. PubMed ID: 6819155
[TBL] [Abstract][Full Text] [Related]
13. 5-Methoxy-N,N-dimethyltryptamine-induced analgesia is blocked by alpha-adrenoceptor antagonists in rats.
Archer T; Danysz W; Jonsson G; Minor BG; Post C
Br J Pharmacol; 1986 Oct; 89(2):293-8. PubMed ID: 2877697
[TBL] [Abstract][Full Text] [Related]
14. Adenosine mediates calcium-induced antinociception and potentiation of noradrenergic antinociception in the spinal cord.
Sawynok J; Reid A; Isbrucker R
Brain Res; 1990 Aug; 524(2):187-95. PubMed ID: 2127235
[TBL] [Abstract][Full Text] [Related]
15. Chronic treatment with antidepressant drugs and the analgesia induced by 5-methoxy-N,N-dimethyltryptamine: attenuation by desipramine.
Danysz W; Minor BG; Post C; Archer T
Acta Pharmacol Toxicol (Copenh); 1986 Aug; 59(2):103-12. PubMed ID: 3776549
[TBL] [Abstract][Full Text] [Related]
16. Involvement of a central dopaminergic system in 5-methoxy-N,N-dimethyltryptamine-induced turning behaviour in rats with lesions of the dorsal raphé nuclei.
Blackburn TP; Cox B; Lee TF
Psychopharmacology (Berl); 1982; 78(3):261-5. PubMed ID: 6818582
[TBL] [Abstract][Full Text] [Related]
17. Effect of 6-hydroxydopamine-induced lesions to ascending and descending noradrenergic pathways on morphine analgesia.
Sawynok J; Reid A
Brain Res; 1987 Sep; 419(1-2):156-65. PubMed ID: 3119144
[TBL] [Abstract][Full Text] [Related]
18. Effects of noradrenaline and serotonin depletions on the neuronal activity of globus pallidus and substantia nigra pars reticulata in experimental parkinsonism.
Delaville C; Navailles S; Benazzouz A
Neuroscience; 2012 Jan; 202():424-33. PubMed ID: 22138505
[TBL] [Abstract][Full Text] [Related]
19. Involvement of spinal monoaminergic pathways in antinociception produced by substance P and neurotensin in rodents.
Naranjo JR; Arnedo A; Molinero MT; Del Rio J
Neuropharmacology; 1989 Mar; 28(3):291-8. PubMed ID: 2471111
[TBL] [Abstract][Full Text] [Related]
20. Involvement of 5-HT2 receptors in the behaviours produced by intrathecal administration of selected 5-HT agonists and the TRH analogue (CG 3509) to rats.
Fone KC; Johnson JV; Bennett GW; Marsden CA
Br J Pharmacol; 1989 Mar; 96(3):599-608. PubMed ID: 2470455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
